ALNYLAM PHARMACEUTICALS INC COM USD0.01 earnings per share and revenue

0HD2 earnings per share for the last quarter are -0.87 USD whereas the estimation was -0.92 USD which accounts for 5.09% surprise. Company revenue for the same period amounts to 500.92 M USD despite the estimated figure of 532.91 M USD. Estimated earnings per share for the next quarter are -0.56 USD, and revenue is expected to reach 580.61 M USD. Also watch annual changes over time to get a bigger picture of 0HD2 earnings per share and revenue dynamics.